Fundraising Fox
Torino · Seed–Series A · 14 people tracked
Find your way into Claris Ventures
Sign up to see every warm intro you have to Claris Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Claris Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Claris Ventures invests equity in early-stage biopharma companies that pair a clear vision with solid scientific evidence. The firm focuses on innovators addressing significant unmet clinical needs across areas including rare diseases, oncology, immunology and other life-threatening conditions. Beyond capital, Claris offers scientific and operational competence and hands-on support to help portfolio companies jump-start clinical development programs, aiming to create value driven by clinical evidence. Its fund, Claris Biotech I, is backed by European public instruments including InnovFin Equity under Horizon 2020, the European Fund for Strategic Investments, AlpGIP, and the Pan-European Guarantee Fund.
Source: firm website, verified Sep 27, 2026.
Team · 14 people
from the firm's website & public directories
Partner at Claris Ventures with a PhD in Immunology and an Executive MBA, bringing experience in business development and strategy across pharma and biotech.
Venture capital investor with a decade of experience across firms including Innogest SGR, LVenture Group, Invitalia Ventures SGR and Vertis SGR. He holds a degree in Management Engineering from the Polytechnic University of Turin and completed a venture capital program at Berkeley Haas.
Investment Manager at Claris Ventures; a mechanical engineer with an MBA who works at the intersection of data analysis and early-stage biotech, with prior operational and research roles.
Supports internal accounting and administration at Claris Ventures, with experience in general accounting, administrative operations and payroll.
Independent Director and entrepreneur with experience in international business development and governance roles within the Italian innovation ecosystem.
Senior Associate at Claris Ventures with a background in molecular biotechnology and neuroscience; supports early-stage biotech investments via scientific assessment and due diligence.
Senior Advisor and healthcare executive with MD and MBA training and leadership experience across pharma and biotech, including founding and scaling ventures.
Senior Advisor and financial executive with experience originating and managing private equity transactions, including development capital, buyouts and listings.
Senior Advisor and finance professional with three decades across investment banking, private equity, fund management and seed/impact investing.
Entrepreneur in Residence and pharmaceutical physician with expertise in RNA therapeutics, infectious diseases and clinical development; supports scientific evaluation and portfolio strategy.
Oversees finance and administration at Claris Ventures, with prior experience in audit, post-deal accounting and financial analysis.
Senior Advisor and pharmacist / EU Qualified Person with deep experience in pharmaceutical development, corporate ventures and strategic investments in oncology and rare diseases.
Associate at Claris Ventures; a biomedical engineer supporting sourcing and assessment of early-stage biotech opportunities and due diligence.
Founder mafia
2 people who came through Claris Ventures went on to found or lead other companies.
What they invest in
from 10 of 12 portfolio companiesBiotech ×10Healthtech ×5Medical Devices ×4Deep Tech ×3AI & Machine Learning ×2Longevity ×2Digital Health ×1
HQs:Italy×3
Investments · 12 tracked
founders shown can be your intro pathBy year:2025 · 32023 · 12022 · 15 dated
Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies.
BiotechDeep TechHealthtechMedical Devices
Pietro Puglisi(Chief Executive Officer)in
Co-investorsExor VenturesItalian Angels for GrowthClub degli InvestitoriOra Global
ALKemist Bio develops immunotherapies targeting the ALK oncogene in cancer by engineering autologous T cells with synthetic receptors to recognize and eliminate ALK-positive tumor cells.
BiotechDigital HealthMedical Devices
Roberto Chiarle
Co-investorsClub degli InvestitoriItalian Angels for GrowthLIFTT
Haptena Therapeutics is a biotech company developing next-generation immunotherapies for oncogene-driven, genetically defined cancers, starting with KRAS-driven tumors.
BiotechHealthtech
Chiara Ambrogio(Co-founder)Roberto Chiarle(Co-founder)
Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction.
BiotechMedical Devices
Mauro Giacca(Founder (Professor of Cardiovascular Sciences))
IAMA Therapeutics develops small-molecule drugs for autism, epilepsies, and other central nervous system disorders, focusing on inhibiting cation-chloride cotransporters to correct atypical brain activity.
BiotechDeep Tech
Co-investorsCDP Venture CapitalIndaco Venture Partners
Kither Biotech is a clinical-stage biotech company developing inhaled cell signal transduction modulators targeting the PI3Kγ signaling axis for respiratory diseases such as COPD, non-cystic fibrosis bronchiectasis, cystic fibrosis, and idiopathic pulmonary fibrosis.
BiotechHealthtech
Co-investors3B Future Health FundCDP Venture CapitalElysia CapitalItalian Angels for GrowthClub degli Investitori
Neophore develops a small-molecule therapeutic that transiently inhibits DNA Mismatch Repair (MMR) to convert MMR-proficient tumours into an MMR-deficient state, making them responsive to cancer immunotherapy.
AI & Machine LearningBiotechLongevity
Co-investors3B Future Health FundAstellas Venture Management LLCItalian Angels for GrowthLIFTTNeva Sgr.
PAGE Therapeutics is an oncology drug development company developing compounds that disrupt cell-cell adhesion to dissolve circulating tumor cell (CTC) clusters and block cancer metastasis.
BiotechHealthtech
Nicola Aceto(Co-founder, Chief Science Officer)inChristoph Rochlitz(Co-founder & Chief Medical Officer)inProf. Dr. Med. Christoph Rochlitz(Co-founder, Chief Medical Officer)Daniele Scarinci(Chief Executive Officer / Executive Director)inKatharina Venturi(Chief Operating Officer)in
Co-investorsXGEN Venture
Resalis Therapeutics develops antisense oligonucleotide therapies targeting microRNA pathways for metabolic disorders.
BiotechHealthtechLongevityMedical DevicesTurin, IT
Riccardo Panella(Chief Scientific Officer & Co-Founder)inSakari Kauppinen(Chief Technology Officer & Co-Founder)in
Co-investorsItalian Angels for GrowthSunstone Capital
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesV-Bio VenturesVertis SGRVI Partners+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Arbitro per le Controversie FinanziarieRepron Therapeutics
Portfolio news
latest coverage across their companiesLever Bio · finsmes.com · May 28, 2025
Frequently asked questions
- How many investments has Claris Ventures made?
- Claris Ventures has 12 tracked investments, including 3 dated in the last 24 months.
- What stage does Claris Ventures invest at?
- Claris Ventures invests at the Seed, Series A stages.
- What sectors does Claris Ventures focus on?
- Claris Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Claris Ventures located?
- Claris Ventures is headquartered in Torino, IT.
- Does Claris Ventures lead rounds?
- Claris Ventures typically participates in rounds rather than leading them.
- Who does Claris Ventures co-invest with?
- Claris Ventures most often shares deals with Italian Angels for Growth, 3B Future Health Fund, CDP Venture Capital, among 14 tracked co-investors.
Media · Podcasts & interviews
featuring the teamPietro Puglisi (Claris Ventures): Sostenere la crescita e dare visione con investimenti nel settore
Sanità33 · Pietro Puglisi
Images
Co-investors · 3
CDP Venture Capital SGR is Italy's leading venture capital fund manager, investing directly and indirectly in strategic sectors to support Italian entrepreneurship and innovation.
3B Future Health Fund invests in early-stage private healthcare and biotech companies in the US, Europe and Israel that address high unmet patient needs, with a focus on oncology and rare diseases.
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
Firms observed investing alongside Claris Ventures, from public investor directories. Shared companies are the overlap with Claris Ventures's recorded portfolio.
Similar investors
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Future Positive Capital is a venture firm that backs entrepreneurs building companies aimed at solving universal challenges at planetary scale across science and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.